Mark Curtis

Corporate and commercial.

Mark Curtis is head of the firm’s international corporate and commercial practice group. Mark primarily advises financial institutions, funds and corporates on public and private mergers and acquisitions and related work. He has considerable experience in the life sciences sector and has advised on a number of securities offerings and mergers and acquisitions transactions in the healthcare market as well as significant transactions in the TMT and financial institutions sectors. Mark’s recent experience includes advising Telefónica on its £17.8bn offer for O2 plc and £2bn disposal of Airwave, a number of hedge funds on concert party and strategic issues relating to UK public M&A situations. Mark also led the team advising The Bank of Nova Scotia on the acquisition of the synthetic prima brokerage business of Daiwa Capital Markets. Mark has been recognised in The Legal 500 as ‘spearheading advice on corporate finance and M&A matters’ in the pharmaceutical and biotechnology sector.